• Team
  • Approach
  • Portfolio
  • News
  • Blog
  • Contact
  • Investor Login
  • Team
  • Approach
  • Portfolio
  • News
  • Blog
  • Investor Login

BIAL Goes Global with New US Research Center and Acquisition of Promising Parkinson’s Disease Programs

BIAL Biotech to be based in Cambridge, Massachusetts and will be a ResearchCenter of Excellence dedicated to genetically-defined Parkinson’s disease• LTI-291 clinical program and other… Read More

Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering

WATERTOWN, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a… Read More

Trefoil Therapeutics Begins First Clinical Trial of Regenerative Treatment for Patients with Corneal Endothelial Dystrophies

Phase 1/2 “INTREPID” trial to evaluate safety and ability of engineered FGF-1 to regenerate corneal endothelial cells August 19, 2020 07:00 AM Eastern Daylight… Read More

Atsena Therapeutics acquires exclusive rights to Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis

Therapy currently being evaluated in Phase I/II clinical study Company formed with $8.15 million Series 1; led by founding investors Hatteras Venture Partners and the… Read More

Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients

– Kymera to receive $150 million upfront with more than $2 billion in potential milestones plus royalty payments – – Kymera to retain option during clinical development… Read More

Shattuck Labs Announces Closing of $118 Million Series B Financing

  Financing will advance two ARC™ clinical programs and expand pipeline development —   DURHAM, NC and AUSTIN, TX – June 15, 2020 – Shattuck… Read More

PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients

PhaseBio receives clearance of IND application from U.S. FDA under Coronavirus Treatment Acceleration Program (CTAP) “VANGARD” trial will assess the efficacy and safety of PB1046… Read More

AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The… Read More

Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform

CAMBRIDGE, Mass., March 12, 2020 /PRNewswire/ — Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients, today… Read More

HealthStream Acquires NurseGrid, #1 Rated and Top Downloaded App for Nurses

NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthStream (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, today announced that it has acquired… Read More

  • Team
  • Approach
  • Portfolio
  • News
  • Blog
  • Contact
  • Investor Login